close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
99 100 Next >
BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Files Orphan Drug Designation Application for NV-387 as Measles Treatment
Via Investor Brand Network
Topics Intellectual Property
Tickers NNVC
Exposures COVID-19 Intellectual Property Product Safety
News headline image
UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing
Via NewMediaWire
Tickers HYDI
Exposures Product Safety
UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing
Via TheNewswire.com
Tickers HYDI
Exposures Product Safety
News headline image
Viatris at a Crossroads: Transitioning from Generic Giant to Specialty Powerhouse
Via Finterra
Topics Economy World Trade
Tickers PFE SQ TEVA VTRS
Exposures Interest Rates Product Safety Tariff
News headline image
The Measurement Giant Reimagined: A Deep Dive into Waters Corporation (WAT) in 2026
Via Finterra
Topics Economy
Tickers A BLK DHR GS JPM SQ
Exposures Economy Product Safety Supply Chain
News headline image
Caramel Ingredients Market Size to Reach USD 5.28 Billion by 2031 as Clean-Label and Natural Color Demand Accelerates
Via Press Release Distribution Service
Exposures Product Safety
News headline image
The Vertical Integration of Wellness: A Deep Dive into Hims & Hers Health (HIMS)
Via Finterra
Topics Artificial Intelligence Intellectual Property Lawsuit
Tickers AMZN BAC C HIMS LLY RDDT
Exposures Artificial Intelligence Financial Intellectual Property
News headline image
Hydromer, Inc. Announces Expansion Into UV Coating and Curing Equipment Manufacturing
Via NewMediaWire
Tickers HYDI
Exposures Product Safety
Hydromer, Inc. Announces Expansion Into UV Coating and Curing Equipment Manufacturing
Via TheNewswire.com
Tickers HYDI
Exposures Product Safety
News headline image
FDA Rejection Clouds Path For REGENXBIO&#39;s Rare Disease Treatment ↗
Via Benzinga
Exposures Product Safety
News headline image
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
Via FinancialNewsMedia
Tickers ABBV AZN HELP JNJ TAK
Exposures Product Safety
News headline image
Prozac For Teen Depression: Side Effects & Safety Resource For Parents Released
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Anxiety Medications & Treatment Programs for Teens: Parent Resource Released
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting
Via Newsfile
Tickers TLTFF TSX-V:TLT
Exposures Product Safety
News headline image
Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial
Via Newsfile
Tickers PHIO
Exposures Product Safety
News headline image
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial
Via Newsfile
Tickers TBRIF TSX-V:THRM
Exposures Product Safety
News headline image
Nio Stock Rises Premarket: Investors Look Past China Software Recall Toward ES9 Flagship SUV Launch ↗
Via Stocktwits
Topics Product Recall
Tickers BMWYY NIO NVDA TSLA
Exposures Legal Product Safety
News headline image
Why MSLE Stock Gave Up All Nasdaq Debut Gains And Fell 8% After Hours ↗
Via Stocktwits
Tickers MSLE
Exposures Product Safety
News headline image
Regenxbio Stock Still Has Over 300% Upside Despite FDA Pushback On Hunter Syndrome Drug: Clear Street ↗
Via Stocktwits
Tickers RGNX
Exposures Product Safety
News headline image
Why Did RGNX Shares Plummet 19% After-Hours Today? ↗
Via Stocktwits
Tickers IWM RGNX VTI XBI
Exposures Product Safety
News headline image
Stock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit ↗
Via The Motley Fool
Topics Artificial Intelligence Lawsuit Stocks
Tickers HIMS NVO
Exposures Artificial Intelligence Financial Legal
News headline image
Online Semaglutide Program For Medical Weight Loss: Telehealth Service Announced
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Compounded GLP-1 & GIP Tirzepatide Semiglutide Online Medications Announced
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Hims & Hers Collapses After FDA Vows to Restrict Copycat GLP-1 Pill. Is the Stock Toast? ↗
Via The Motley Fool
Topics Intellectual Property Lawsuit
Tickers HIMS NVO
Exposures Financial Intellectual Property Legal
News headline image
FDA Uncertainty Pushes Analyst To Lower Hims &amp; Hers Forecast ↗
Via Benzinga
Tickers BAC
Exposures Product Safety
News headline image
Nio Recalls 246K EVs For &#39;Screen Blackouts&#39; As Firm Hits First-Ever Profit Milestone ↗
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
News headline image
Why Novo Nordisk Stock Just Popped ↗
Via The Motley Fool
Topics Intellectual Property Lawsuit
Tickers HIMS NVO
Exposures Financial Intellectual Property Legal
News headline image
Why Hims & Hers Stock Just Got Destroyed ↗
Via The Motley Fool
Topics Lawsuit
Tickers HIMS NVO
Exposures Financial Legal Product Safety
News headline image
The GLP-1 Gold Rush Hits a Wall: Novo Nordisk Sues Hims & Hers as FDA Crackdown Triggers 20% Stock Crash
Via MarketMinute
Topics Intellectual Property Lawsuit
Tickers HIMS LLY NVO
Exposures Financial Intellectual Property Legal
News headline image
FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains ↗
Via Stocktwits
Topics Lawsuit
Tickers AVDE HIMS NVO PPH PVAL
Exposures Financial Legal Product Safety
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today